Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Vaxart (VXRT) stock

Learn how to easily invest in Vaxart stock.

Vaxart, Inc
NASDAQ: VXRT - USD
BIOTECHNOLOGY
$8.03
-$0.05 (-0.62%)

Vaxart, Inc is a biotechnology business based in the US. Vaxart shares (VXRT) are listed on the NASDAQ and all prices are listed in US Dollars. Vaxart employs 28 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Vaxart

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VXRT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Vaxart stock price (NASDAQ: VXRT)

Use our graph to track the performance of VXRT stocks over time.

Vaxart shares at a glance

Information last updated 2021-07-22.
Latest market close$6.87
52-week range$3.71 - $15.80
50-day moving average $7.65
200-day moving average $7.33
Wall St. target price$13.40
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.03

Buy Vaxart shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Vaxart stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Vaxart price performance over time

Historical closes compared with the close of $6.87 from 2021-06-04

1 week (2021-07-17) N/A
1 month (2021-06-28) -21.31%
3 months (2021-04-28) -18.60%
6 months (2021-01-24) N/A
1 year (2020-07-24) N/A
2 years (2019-07-24) N/A
3 years (2018-07-24) N/A
5 years (2016-07-24) N/A

Vaxart financials

Revenue TTM $1.7 million
Gross profit TTM $-15,817,000
Return on assets TTM -22.2%
Return on equity TTM -45.23%
Profit margin 0%
Book value $1.49
Market capitalisation $1 billion

TTM: trailing 12 months

Shorting Vaxart shares

There are currently 23.7 million Vaxart shares held short by investors – that's known as Vaxart's "short interest". This figure is 1.8% down from 24.1 million last month.

There are a few different ways that this level of interest in shorting Vaxart shares can be evaluated.

Vaxart's "short interest ratio" (SIR)

Vaxart's "short interest ratio" (SIR) is the quantity of Vaxart shares currently shorted divided by the average quantity of Vaxart shares traded daily (recently around 13.7 million). Vaxart's SIR currently stands at 1.73. In other words for every 100,000 Vaxart shares traded daily on the market, roughly 1730 shares are currently held short.

However Vaxart's short interest can also be evaluated against the total number of Vaxart shares, or, against the total number of tradable Vaxart shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Vaxart's short interest could be expressed as 0.19% of the outstanding shares (for every 100,000 Vaxart shares in existence, roughly 190 shares are currently held short) or 0.1954% of the tradable shares (for every 100,000 tradable Vaxart shares, roughly 195 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Vaxart.

Find out more about how you can short Vaxart stock.

Vaxart share dividends

We're not expecting Vaxart to pay a dividend over the next 12 months.

Have Vaxart's shares ever split?

Vaxart's shares were split on a 1:11 basis on 13 February 2018. So if you had owned 11 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Vaxart shares – just the quantity. However, indirectly, the new 1000% higher share price could have impacted the market appetite for Vaxart shares which in turn could have impacted Vaxart's share price.

Vaxart share price volatility

Over the last 12 months, Vaxart's shares have ranged in value from as little as $3.71 up to $15.8. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vaxart's is 0.3903. This would suggest that Vaxart's shares are less volatile than average (for this exchange).

Vaxart overview

Vaxart, Inc. , a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI. 1 and GII. 4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which completed Phase I clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. Vaxart, Inc.

Stocks similar to Vaxart

Frequently asked questions

What percentage of Vaxart is owned by insiders or institutions?
Currently 0.578% of Vaxart shares are held by insiders and 38.928% by institutions.
How many people work for Vaxart?
Latest data suggests 28 work at Vaxart.
When does the fiscal year end for Vaxart?
Vaxart's fiscal year ends in December.
Where is Vaxart based?
Vaxart's address is: 170 Harbor Way, South San Francisco, CA, United States, 94080
What is Vaxart's ISIN number?
Vaxart's international securities identification number is: US92243A2006
What is Vaxart's CUSIP number?
Vaxart's Committee on Uniform Securities Identification Procedures number is: 053761102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site